ISRCTN16400909已完成不适用
Tianeptine for the treatment of fibromyalgia: a prospective double-blind, randomised, single-centre, placebo-controlled, parallel group study
Fundacion para la Fibromialgia y el Síndrome de Fatiga Crónica (Spain)0 个研究点目标入组 60 人开始时间: 2006年10月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged from 40 to 50 years, both genders
- •2. Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) criteria
排除标准
- •1. Psychiatric illness
- •2. Major depression
- •3. Suicidal risk
- •4. Substance abuse
- •5. Pulmonary dysfunction
- •6. Renal impairment
- •7. Active cardiac disease
- •8. Liver disease
- •9. Autoimmune disease
- •10. Cancer
- •11. Sleep apnea
- •12. Chronic fatigue syndrome
- •13. Inflammatory bowel disease
- •14. Contraindications to tianeptine
研究者
相似试验
招募中
不适用
Effect of stimulation with electrical current in fibromyalgia:randomized clinical trialC05.651.324FibromyalgiaRBR-3rqmghniversidade Federal de Sergipe
已完成
2 期
Neurotropin Treatment of FibromyalgiaFibromyalgiaNCT00366535National Institute of Nursing Research (NINR)56
Unknown
3 期
Randomised Controlled Trial of Memantine in FibromyalgiaFibromyalgiaNCT01653457Aragon Institute of Health Sciences60
已完成
2 期
Gabapentin in Fibromyalgia Trial (GIFT)FibromyalgiaNCT00057278National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)150
已完成
不适用
Moxonidine for the treatment of fibromyalgia: a prospective double-blind, randomised, single-centre, placebo-controlled, parallel group studyMusculoskeletal DiseasesFibromyalgiaISRCTN70535562Foundation for Fibromyalgia and Chronic Fatigue Syndrome (Spain)60